Collaborate

Quantum Discovery

Richly annotated data and/or specimens spanning 12+ years of the I-SPY trial are available to approved investigators by completing an I-SPY Concept Proposal.

Concept Proposals

Access decades of trial data.

Richly annotated data and/or specimens spanning 12+ years of the I-SPY trial are available to approved investigators by completing an I-SPY Concept Proposal.

The Data Access and Publications Committee (DAPC) reviews all proposals to ensure scientific rigor, feasibility, and alignment with QLHC's mission to accelerate patient-centric research.

I-SPY Concept Proposal

Approved investigators gain access to one of medicine's most comprehensive multi-modal clinical datasets. Submit a proposal to the DAPC to begin your research journey with QLHC.

  • 12+ years of longitudinally collected trial data
  • 500,000+ annotated biospecimens
  • Multi-modal: genomic, imaging, and liquid biopsy
  • Cross-trial analysis capabilities
  • Governed, secure data environment
Quantum Discovery

Not a data lake. A discovery engine.

Quantum Discovery is Quantum Leap Healthcare Collaborative's secure data fabric platform — purpose-built to operationalize and analyze one of medicine's most comprehensive multi-modal clinical datasets. This is not a data lake. It is an active, governed, integrated environment where clinical trial data becomes a tool for discovery.

DATA ACCESS

A Dataset Built for the Next Era of Precision Medicine

Across QLHC's portfolio of adaptive platform trials — including I-SPY 2.2, I-SPY Phase 1b, RECAST DCIS, EOP, I-SPY COVID, and ISPY ARDS — Quantum Discovery provides access to a rare depth of longitudinally collected, richly annotated data.

Data Type
Detail
Annotated Biospecimens
500,000+ specimens with clinical annotation
ctDNA
Longitudinally collected across treatment timepoints
MRI
Longitudinal imaging across treatment course
DNA / RNA Sequencing
WGS, WES, and RNA-Seq
All data is integrated within a single governed fabric — enabling cross-modal, cross-trial analysis that siloed repositories simply cannot support.
For Academic Researchers
Accelerate Your Science. Skip the Infrastructure.

DAPC-approved investigators gain secure, structured access to Quantum Discovery's curated data fabric — without building the data infrastructure themselves. Whether your research centers on biomarker discovery, treatment response modeling, or disease biology across oncology and critical care, Quantum Discovery delivers the data you need in a format ready for analysis.

Submit a DAPC proposal to begin
For Biopharma Partners
The Data Infrastructure Your Development Programs Demand

Drug development decisions need multi-modal, longitudinal evidence — not snapshot datasets. Quantum Discovery gives biopharma partners governed access to clinical, genomic, imaging, and liquid biopsy data collected across QLHC's adaptive trials — spanning breast cancer, DCIS, and critical illness — in an architecture purpose-built for the analytical demands of modern drug development.

Built to meet the standards leading research funders are requiring, Quantum Discovery is where rigorous adaptive trial design meets next-generation data operationalization.

Explore partnership opportunities

Governed. Secure. Integrated.

Quantum Discovery maintains the highest standards for data governance, security, compliance, and patient privacy. All access is granted through a rigorous approval process, ensuring that data is used responsibly to advance science and improve patient outcomes.